Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...

A tactic used by a growing number of scammers is to impersonate help centres in order to trick victims into sharing their screens via WhatsApp. By doing so, they can obtain sensitive information like ...

Meta is betting on cost-cutting measures and is killing its own macOS app for its messenger service. Now you have to use the website. Anyone who still has friends or family who use Facebook's ...

Replimune received FDA acceptance for its RP1 BLA resubmission in advanced melanoma, with a PDUFA date set for April 2026. REPL stock surged nearly 100% on the news, but FDA acceptance only restarts ...

Replimune Group (REPL) has drawn attention after presenting updated clinical data from its IGNYTE phase 2 trial at the ESMO Congress 2025. The study combined RP1 with nivolumab in patients with acral ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in UnitedHealth Group Inc (Symbol: UNH), where a total volume of 92,988 contracts has ...

The Chairman, Board of Trustees (BoT) of the Peoples Democratic Party (PDP), Senator Adolphus Wabara, has questioned the legitimacy of Governor Douye Diri of Bayelsa State to remain in office ...